Neuropace Inc (NPCE) returns
Neuropace returns over 5 years
$1,000 invested in Neuropace five years ago was worth $811.35 at the close on October 30, 2026, with dividends reinvested: an average return of -4.1% a year. The same $1,000 in the S&P 500 (SPY) became $1,760.
Total return by period
| Period | Total return | A year, on average | $1,000 became | S&P 500 (SPY) |
|---|---|---|---|---|
| 1 month | -10.6% | — | $893.90 | -0.9% |
| 3 months | -10.5% | — | $894.55 | +2.1% |
| Year to date | -20.3% | — | $796.63 | +11.7% |
| 1 year | +24.7% | — | $1,247 | +12.4% |
| 3 years | +85.2% | +22.8% | $1,852 | +88.5% |
| 5 years | -18.9% | -4.1% | $811.35 | +76.0% |
Neuropace return by calendar year
| Year | NPCE | S&P 500 (SPY) | Difference |
|---|---|---|---|
| 2026 to date | -20.3% | +11.7% | -32.0% |
| 2025 | +38.0% | +17.7% | +20.3% |
| 2024 | +8.5% | +24.9% | -16.3% |
| 2023 | +591.9% | +26.2% | +565.8% |
| 2022 | -85.2% | -18.2% | -67.0% |
Past returns do not predict future returns. Returns are computed from our daily closes, adjusted for splits and with dividends reinvested on their ex-dates; taxes and trading costs are left out.
See also: NPCE financials
No forecast, no recommendation. This page describes Neuropace Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.